Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer

le van Eerden, Ruben A G, Mathijssen, Ron H J, Koolen, Stijn L W
Foilsithe in Int J Nanomedicine (2020)

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

le Koolen, Stijn L W, Oostendorp, Roos L, Beijnen, Jos H, Schellens, Jan H M, Huitema, Alwin D R
Foilsithe 2010

Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors

le van Eerden, Ruben A. G., Oomen-de Hoop, Esther, Noordam, Aad, Mathijssen, Ron H. J., Koolen, Stijn L. W.
Foilsithe in Pharmaceuticals (Basel) (2021)

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

le Braal, C. Louwrens, Jongbloed, Elisabeth M., Wilting, Saskia M., Mathijssen, Ron H. J., Koolen, Stijn L. W., Jager, Agnes
Foilsithe in Drugs (2020)

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

le Klopp-Schulze, Lena, Mueller-Schoell, Anna, Neven, Patrick, Koolen, Stijn L. W., Mathijssen, Ron H. J., Joerger, Markus, Kloft, Charlotte
Foilsithe in Front Pharmacol (2020)

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

le Hurkmans, Daan P, Jensen, Christina, Koolen, Stijn L W, Aerts, Joachim, Karsdal, Morten Asser, Mathijssen, Ron H J, Willumsen, Nicholas
Foilsithe in J Immunother Cancer (2020)

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients

le Kuip, Evelien J. M., Zandvliet, Maarten L., Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.
Foilsithe in Br J Clin Pharmacol (2016)

A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions

le de Rouw, Nikki, Visser, Sabine, Koolen, Stijn L. W., Aerts, Joachim G. J. V., van den Heuvel, Michel M., Derijks, Hieronymus J., Burger, David M., ter Heine, Rob
Foilsithe in Cancer Chemother Pharmacol (2019)

Development of [(225)Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC

le Hooijman, Eline L., Chalashkan, Yozlem, Ling, Sui Wai, Kahyargil, Figen F., Segbers, Marcel, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn L. W., Brabander, Tessa, de Blois, Erik
Foilsithe in Pharmaceutics (2021)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma

le Hussaarts, Koen G. A. M., van Doorn, Leni, Bins, Sander, Sprengers, Dave, de Bruijn, Peter, van Leeuwen, Roelof W. F., Koolen, Stijn L. W., van Gelder, Teun, Mathijssen, Ron H. J.
Foilsithe in Pharmaceuticals (Basel) (2021)

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients

le van Doorn, Leni, Crombag, Marie-Rose B. S., Rier, Hánah N., van Vugt, Jeroen L. A., van Kesteren, Charlotte, Bins, Sander, Mathijssen, Ron H. J., Levin, Mark-David, Koolen, Stijn L. W.
Foilsithe in Pharmaceuticals (Basel) (2021)

Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain

le Agema, Bram C., Oosten, Astrid W., Sassen, Sebastiaan D.T., Rietdijk, Wim J.R., van der Rijt, Carin C.D., Koch, Birgit C.P., Mathijssen, Ron H.J., Koolen, Stijn L.W.
Foilsithe in Cancers (Basel) (2021)

Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer

le Kuip, Evelien J. M., Oldenmenger, Wendy H., Thijs—Visser, Martine F., de Bruijn, Peter, Oosten, Astrid W., Oomen—de Hoop, Esther, Koolen, Stijn L. W., Van der Rijt, Carin C. D., Mathijssen, Ron H. J.
Foilsithe in PLoS One (2018)

Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients

le Agema, Bram C., Koolen, Stijn L.W., de With, Mirjam, van Doorn, Nadia, Heersche, Niels, Oomen-de Hoop, Esther, Visser, Sabine, Aerts, Joachim G.J.V., Bins, Sander, van Schaik, Ron H.N., Mathijssen, Ron H.J.
Foilsithe in Genes (Basel) (2020)

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy

le Kuip, Evelien J. M., Oldenmenger, Wendy H., Oomen-de Hoop, Esther, Verduijn, Gerda M., Thijs-Visser, Martine F., de Bruijn, Peter, van Meerten, Esther, Koolen, Stijn L. W., Mathijssen, Ron H. J., van der Rijt, Carin C. D.
Foilsithe in Cancers (Basel) (2018)

Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer Patients

le Bins, Sander, Huitema, Alwin D. R., Laven, Pim, Bouazzaoui, Samira el, Yu, Huixin, van Erp, Nielka, van Herpen, Carla, Hamberg, Paul, Gelderblom, Hans, Steeghs, Neeltje, Sleijfer, Stefan, van Schaik, Ron H. N., Mathijssen, Ron H. J., Koolen, Stijn L. W.
Foilsithe in Clin Pharmacokinet (2018)

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio

le Lee, Clara Inkyung, Low, Siew Kee, Maldonado, Ricardo, Fox, Peter, Balakrishnar, Bavanthi, Coulter, Sally, de Bruijn, Peter, Koolen, Stijn L.W., Gao, Bo, Lynch, Jodi, Zdenkowski, Nicholas, Hui, Rina, Liddle, Christopher, Mathijssen, Ron H.J., Wilcken, Nicholas, Wong, Mark, Gurney, Howard
Foilsithe in Breast (2020)

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

le Bins, Sander, Basak, Edwin A., el Bouazzaoui, Samira, Koolen, Stijn L. W., Oomen – de Hoop, E., van der Leest, Cor H., van der Veldt, Astrid A. M., Sleijfer, Stefan, Debets, Reno, van Schaik, Ron H. N., Aerts, Joachim G. J. V., Mathijssen, Ron H. J.
Foilsithe in Br J Cancer (2018)

CD45RA(+)CCR7(−) CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

le Kunert, Andre, Basak, Edwin A., Hurkmans, Daan P., Balcioglu, Hayri E., Klaver, Yarne, van Brakel, Mandy, Oostvogels, Astrid A. M., Lamers, Cor H. J., Bins, Sander, Koolen, Stijn L. W., van der Veldt, Astrid A. M., Sleijfer, Stefan, Mathijssen, Ron H. J., Aerts, Joachim G. J. V., Debets, Reno
Foilsithe in J Immunother Cancer (2019)

Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

le Hurkmans, Daan P., Basak, Edwin A., Schepers, Nina, Oomen-De Hoop, Esther, Van der Leest, Cor H., El Bouazzaoui, Samira, Bins, Sander, Koolen, Stijn L. W., Sleijfer, Stefan, Van der Veldt, Astrid A. M., Debets, Reno, Van Schaik, Ron H. N., Aerts, Joachim G. J. V., Mathijssen, Ron H. J.
Foilsithe in J Immunother Cancer (2020)